Audited Supplier
169590-42-5
Chemical Medicine Raw Materal
GMP, USP, Ep, Bp
Medicine Grade
Chemical Medicine Raw Materal
Powder
Not Volatile
Celecoxib
C17h14f3n3o2s
381.37
169590-42-5 (184007-95-2)
Mesochem
25kg/Barrel or 250kg/Barrel
GMP
Jiang Xi China
29420090
Product Description
 Identification | |||
| Name | Celecoxib | ||
| Synonyms | 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide | ||
| Molecular Structure | |||
| Molecular Formula | C17H14F3N3O2S | ||
| Molecular Weight | 381.37 | ||
| CAS Registry Number | 169590-42-5 (184007-95-2) | ||
| Properties | |||
| Melting point | 157-159 ºC | ||
| Safety Data | |||
| MSDS | Available | ||
| Market Analysis Reports | |||
| |||
2. Competitive price
3. Good service
4. Stock availability
5. Flexible payment
6. Off- white to white crystalline powder
7. Assay: NLT 99.0%
8. Can supply its intermediate
9. We have this produts in stock all the year around.
Beijing Mesochem Technology Co., Ltd. Is founded in 2009 as an independent high-tech enterprises specializing in Pharmaceutical chemicals and fine chemicals, it aims to to adapt to the business development of Beijing Huafeng United Technology Co., Ltd established in 2005.
The company locates in "Pharm Valley"'- Beijing Economic and Technological Development Zone(BDA), devotes to active pharmaceutical ingredient, intermediates and Pharmaceutical technology development services. It has independent R&D ability and right of import-export operations and has already established stable cooperation relationship with hundreds of pharmaceutical companies and research institutions both at home and abroad.
Beijing Mesochem Technology Co., Ltd has two production base at Xingan (Jiangxi Province) and Xiangyang (Hubei province), with production area about 67000 m2 and various of manufacturing equipment amount to 30000L, it has the ability of R&D, pilot production and commercial production. 80% of the products are exported to Europe, North America, South America, India and Pakistan, Southeast Asia and so on.
